Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for IMTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 555.34M
March 31, 2026 625.95M
December 31, 2025 660.44M
September 30, 2025 609.30M
June 30, 2025 665.93M
March 31, 2025 693.16M
December 31, 2024 720.86M
September 30, 2024 644.22M
June 30, 2024 671.95M
March 31, 2024 705.38M
December 31, 2023 563.33M
September 30, 2023 463.15M
June 30, 2023 447.52M
March 31, 2023 411.21M
Date Value
December 31, 2022
September 30, 2022
June 30, 2022 385.04M
March 31, 2022 313.97M
December 31, 2021 198.61M
September 30, 2021 230.53M
June 30, 2021 256.75M
March 31, 2021 279.45M
December 31, 2020 311.57M
September 30, 2020 331.90M
June 30, 2020 121.22M
March 31, 2020 133.61M
December 31, 2019 150.73M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
MediGene AG --
InflaRx NV 190.83M
BioNTech SE 23.26B
Moderna, Inc. 10.96B
Intellia Therapeutics, Inc. 857.16M

Total Assets (Quarterly) Related Metrics